HRP20010619A2 - Hetrocyclic benzenesulphonamide compounds as bradykinine antagonists - Google Patents
Hetrocyclic benzenesulphonamide compounds as bradykinine antagonists Download PDFInfo
- Publication number
- HRP20010619A2 HRP20010619A2 HR20010619A HRP20010619A HRP20010619A2 HR P20010619 A2 HRP20010619 A2 HR P20010619A2 HR 20010619 A HR20010619 A HR 20010619A HR P20010619 A HRP20010619 A HR P20010619A HR P20010619 A2 HRP20010619 A2 HR P20010619A2
- Authority
- HR
- Croatia
- Prior art keywords
- methyl
- group
- substance
- yield
- procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Transplantation (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9902412A FR2790260B1 (fr) | 1999-02-26 | 1999-02-26 | Nouveaux composes de n-(benzenesulfonamide), procede de preparation et utilisation en therapeutique |
| PCT/FR2000/000396 WO2000050418A1 (fr) | 1999-02-26 | 2000-02-17 | Composes heterocycliques de benzenesulfonamide en tant qu'antagonistes de la bradykinine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20010619A2 true HRP20010619A2 (en) | 2002-08-31 |
Family
ID=9542576
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20010619A HRP20010619A2 (en) | 1999-02-26 | 2000-02-17 | Hetrocyclic benzenesulphonamide compounds as bradykinine antagonists |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6479515B1 (cs) |
| EP (1) | EP1155013B1 (cs) |
| JP (1) | JP4564666B2 (cs) |
| KR (1) | KR20010102057A (cs) |
| CN (1) | CN1340050A (cs) |
| AR (1) | AR022754A1 (cs) |
| AT (1) | ATE245640T1 (cs) |
| AU (1) | AU2809600A (cs) |
| BG (1) | BG105840A (cs) |
| BR (1) | BR0008221A (cs) |
| CA (1) | CA2371853C (cs) |
| CZ (1) | CZ303169B6 (cs) |
| DE (1) | DE60004017T2 (cs) |
| DK (1) | DK1155013T3 (cs) |
| EE (1) | EE04839B1 (cs) |
| ES (1) | ES2202059T3 (cs) |
| FR (1) | FR2790260B1 (cs) |
| HK (1) | HK1041267A1 (cs) |
| HR (1) | HRP20010619A2 (cs) |
| HU (1) | HUP0200281A3 (cs) |
| ID (1) | ID29914A (cs) |
| IL (1) | IL144720A0 (cs) |
| MX (1) | MXPA01008672A (cs) |
| NO (1) | NO20014048L (cs) |
| NZ (1) | NZ513732A (cs) |
| PL (1) | PL199209B1 (cs) |
| PT (1) | PT1155013E (cs) |
| SK (1) | SK286710B6 (cs) |
| TN (1) | TNSN00031A1 (cs) |
| WO (1) | WO2000050418A1 (cs) |
| ZA (1) | ZA200106250B (cs) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6809093B2 (en) | 2000-10-17 | 2004-10-26 | H. Lee Moffitt Cancer & Research Institute, Inc. | 2-substituted heterocyclic compounds |
| US6376514B1 (en) | 2000-10-17 | 2002-04-23 | The Procter & Gamble Co. | Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof |
| US6693099B2 (en) | 2000-10-17 | 2004-02-17 | The Procter & Gamble Company | Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance |
| TW200303742A (en) * | 2001-11-21 | 2003-09-16 | Novartis Ag | Organic compounds |
| EP1572678A4 (en) * | 2002-12-19 | 2008-05-07 | Elan Pharm Inc | SUBSTITUTED N-PHENYL SULPHONAMIDES ALSBRADYKININ ANTAGONISTS |
| EP1633743A1 (en) * | 2003-04-10 | 2006-03-15 | Amgen, Inc. | Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| US20050032868A1 (en) * | 2003-05-02 | 2005-02-10 | Garofalo Albert W. | Selected substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists |
| PE20050525A1 (es) | 2003-05-02 | 2005-09-08 | Elan Pharm Inc | Derivados de pirazol sustituido y compuestos relacionados como antagonistas del receptor de bradiquinina b1 |
| CA2524274A1 (en) * | 2003-05-02 | 2004-11-18 | Elan Pharmaceuticals, Inc. | 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (1-(aminocarbonyl)eth-1-yl) amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases |
| CN101553481A (zh) * | 2006-09-29 | 2009-10-07 | 格吕伦塔尔有限公司 | 取代的磺酰胺衍生物 |
| TWI407960B (zh) | 2007-03-23 | 2013-09-11 | Jerini Ag | 小分子緩激肽ｂ２受體調節劑 |
| AR073304A1 (es) * | 2008-09-22 | 2010-10-28 | Jerini Ag | Moduladores del receptor de bradiquinina b2 de molecula pequena |
| CA2865962A1 (en) * | 2012-02-29 | 2013-09-06 | Institute For Hepatitis And Virus Research | Inhibitors of hepatitis b virus covalently closed circular dna formation and their method of use |
| SI3713928T1 (sl) | 2017-11-24 | 2022-09-30 | Pharvaris Netherlands B.V. | Novi antagonisti receptorja bradikinina B2 |
| AR118982A1 (es) * | 2019-05-23 | 2021-11-17 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| AR118983A1 (es) | 2019-05-23 | 2021-11-17 | Pharvaris Gmbh | Antagonistas cíclicos del receptor b2 de bradiquinina |
| TW202345810A (zh) | 2022-03-25 | 2023-12-01 | 瑞士商帕法瑞斯有限責任公司 | 包含緩激肽ｂ２受體拮抗劑之固態延長釋放組成物 |
| WO2023180577A1 (en) | 2022-03-25 | 2023-09-28 | Pharvaris Gmbh | Therapeutic uses of bradykinin b2-receptor antagonists |
| KR20240161689A (ko) | 2022-03-25 | 2024-11-12 | 파르바리스 게엠베하 | 가용화된 브래디키닌 b2 수용체 길항제를 포함하는 고체 조성물 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3617183A1 (de) | 1985-11-16 | 1987-05-27 | Bayer Ag | Substituierte benzylether |
| US5202336A (en) | 1986-09-24 | 1993-04-13 | Bayer Aktiengesellschaft | Antiflammatory quinolin methoxy phenylsulphonamides |
| DE3632329A1 (de) | 1986-09-24 | 1988-03-31 | Bayer Ag | Substituierte phenylsulfonamide |
| US5610140A (en) | 1991-04-01 | 1997-03-11 | Cortech, Inc. | Bradykinin receptor antagonists with neurokinin receptor blocking activity |
| AU660683B2 (en) | 1991-04-01 | 1995-07-06 | Cortech, Inc. | Bradykinin antagonists |
| TW258739B (cs) | 1992-04-04 | 1995-10-01 | Hoechst Ag | |
| US5610142A (en) | 1992-10-08 | 1997-03-11 | Scios Inc. | Bradykinin antagonist pseudopeptide derivatives of substituted 4-keto-1,3,8-triazaspiro[4.5]decan-3-alkanoic acids |
| AU686115B2 (en) | 1992-11-02 | 1998-02-05 | Fujisawa Pharmaceutical Co., Ltd. | Imidazo (I,2-a) pyridine derivatives as bradykinin antagonists, pharmaceuticals and processes for their preparation |
| US5510380A (en) | 1993-02-19 | 1996-04-23 | Sterling Winthrop, Inc. | Nonpeptide bradykinin antagonists |
| AU680870B2 (en) | 1993-04-28 | 1997-08-14 | Astellas Pharma Inc. | New heterocyclic compounds |
| ATE269310T1 (de) | 1994-10-27 | 2004-07-15 | Fujisawa Pharmaceutical Co | Pyridopyrimidinone, chinoline und anellierte n- heterozyklen als bradykinin-antagonisten |
| JPH0940662A (ja) | 1995-05-24 | 1997-02-10 | Kyowa Hakko Kogyo Co Ltd | 三環式化合物 |
| FR2735128B1 (fr) | 1995-06-07 | 1997-07-25 | Fournier Ind & Sante | Nouveaux composes de benzenesulfonamide, leur procede de preparation et utilisation en therapeutique. |
| FR2737892B1 (fr) | 1995-08-17 | 1997-10-24 | Fournier Ind & Sante | Nouveaux composes de benzenesulfonamide, procede de preparation et utilisation en therapeutique |
| US5834431A (en) | 1995-09-08 | 1998-11-10 | Cortech, Inc. | Des-Arg9 -BK antagonists |
| US5849863A (en) | 1995-09-08 | 1998-12-15 | University Of Colorado | Cytolytic bradykinin antagonists |
| GB9519077D0 (en) | 1995-09-18 | 1995-11-15 | Fujisawa Pharmaceutical Co | New heterocyclic compounds |
| FR2743073B1 (fr) * | 1995-12-29 | 1998-02-20 | Fournier Ind & Sante | Nouveaux composes de 1-benzenesulfonylpyrrolidine, procede de preparation et utilisation en therapeutique |
| AUPN952696A0 (en) | 1996-04-29 | 1996-05-23 | Fujisawa Pharmaceutical Co., Ltd. | New heterocyclic compounds |
| FR2751650B1 (fr) * | 1996-07-24 | 1998-10-09 | Fournier Ind & Sante | Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique |
| FR2756562B1 (fr) * | 1996-12-04 | 1999-01-08 | Fournier Ind & Sante | Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique |
| FR2765222B1 (fr) | 1997-06-27 | 1999-12-31 | Fournier Ind & Sante | Nouveaux composes de n-benzenesulfonyl-l-proline, procede de preparation et utilisation en therapeutique |
-
1999
- 1999-02-26 FR FR9902412A patent/FR2790260B1/fr not_active Expired - Fee Related
-
2000
- 2000-02-17 HR HR20010619A patent/HRP20010619A2/hr not_active Application Discontinuation
- 2000-02-17 JP JP2000600999A patent/JP4564666B2/ja not_active Expired - Fee Related
- 2000-02-17 ES ES00906414T patent/ES2202059T3/es not_active Expired - Lifetime
- 2000-02-17 EE EEP200100444A patent/EE04839B1/xx not_active IP Right Cessation
- 2000-02-17 US US09/889,965 patent/US6479515B1/en not_active Expired - Fee Related
- 2000-02-17 EP EP00906414A patent/EP1155013B1/fr not_active Expired - Lifetime
- 2000-02-17 DK DK00906414T patent/DK1155013T3/da active
- 2000-02-17 PL PL350234A patent/PL199209B1/pl unknown
- 2000-02-17 AU AU28096/00A patent/AU2809600A/en not_active Abandoned
- 2000-02-17 MX MXPA01008672A patent/MXPA01008672A/es unknown
- 2000-02-17 WO PCT/FR2000/000396 patent/WO2000050418A1/fr not_active Ceased
- 2000-02-17 PT PT00906414T patent/PT1155013E/pt unknown
- 2000-02-17 HU HU0200281A patent/HUP0200281A3/hu unknown
- 2000-02-17 BR BR0008221-0A patent/BR0008221A/pt not_active IP Right Cessation
- 2000-02-17 NZ NZ513732A patent/NZ513732A/xx not_active Application Discontinuation
- 2000-02-17 SK SK1192-2001A patent/SK286710B6/sk not_active IP Right Cessation
- 2000-02-17 IL IL14472000A patent/IL144720A0/xx unknown
- 2000-02-17 CA CA002371853A patent/CA2371853C/en not_active Expired - Fee Related
- 2000-02-17 AT AT00906414T patent/ATE245640T1/de active
- 2000-02-17 ID IDW00200101795A patent/ID29914A/id unknown
- 2000-02-17 CZ CZ20013067A patent/CZ303169B6/cs not_active IP Right Cessation
- 2000-02-17 HK HK02103040.2A patent/HK1041267A1/zh unknown
- 2000-02-17 CN CN00803551A patent/CN1340050A/zh active Pending
- 2000-02-17 KR KR1020017010157A patent/KR20010102057A/ko not_active Withdrawn
- 2000-02-17 DE DE60004017T patent/DE60004017T2/de not_active Expired - Lifetime
- 2000-02-18 TN TNTNSN00031A patent/TNSN00031A1/fr unknown
- 2000-02-25 AR ARP000100812A patent/AR022754A1/es unknown
-
2001
- 2001-07-30 ZA ZA200106250A patent/ZA200106250B/en unknown
- 2001-08-20 NO NO20014048A patent/NO20014048L/no not_active Application Discontinuation
- 2001-08-24 BG BG105840A patent/BG105840A/xx unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20010619A2 (en) | Hetrocyclic benzenesulphonamide compounds as bradykinine antagonists | |
| DE69709727T2 (de) | Parazinon thrombin inhibitoren | |
| EP1188754B1 (en) | Substituted pyrazole compounds | |
| KR20030070080A (ko) | 엔-(페닐술포닐) 글리신 유도체와 이들의 치료적 용도 | |
| TW234717B (en) | 1-[2-(arylsulfonylamine)-1-oxoethyl]piperidine derivatives, their preparation and therapeutic applications | |
| SK286779B6 (sk) | N-Heterocyklické deriváty ako inhibítory NOS, spôsob ich prípravy, farmaceutické prostriedky s ich obsahom a ich použitie | |
| JPH01221357A (ja) | ペプチジル複素環 | |
| DE69912429T2 (de) | Hydrazin derivate | |
| DE4243858A1 (de) | Aminosäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung | |
| JPH05504968A (ja) | グリシンアミド誘導体、その製造及びそれを含む医薬品 | |
| DE19939910A1 (de) | Neue Verbindungen, die Tryptase-Aktivität hemmen | |
| JP2000514818A (ja) | ブラジキニン拮抗剤としてのｎ−ベンゼンスルホニル−ｌ−プロリン誘導体 | |
| EP0252727A1 (en) | Novel amino acid derivatives | |
| EP1318996B1 (en) | Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists | |
| CN1326850C (zh) | 三环类法尼基蛋白转移酶抑制剂 | |
| DE69818051T2 (de) | Neue N-(Benzolsulfonyl)-L-prolin-Verbindungen, Verfahren zu ihrer Herstellung und therapeutische Verwendung | |
| EP0882699A1 (en) | Amino compounds and angiotensin iv receptor agonists | |
| USH1729H (en) | Method for preparing compounds employing solid phase synthesis and novel linker-resin | |
| HK1051500B (en) | Cell adhesion inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A1OB | Publication of a patent application | ||
| ODRP | Renewal fee for the maintenance of a patent |
Payment date: 20030131 Year of fee payment: 4 |
|
| ARAI | Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application | ||
| OBST | Application withdrawn |